胚胎小鼠脑切片中迁移神经元和神经胶质祖细胞的延时成像
March 8th, 2024
1.7K views
在大脑皮层的发育过程中，神经元和神经胶质细胞起源于脑室内壁的心室区，并向大脑表面迁移。这个过程涉及许多基因。该协议介绍了迁移神经元和神经胶质祖细胞的延时成像技术。
在大脑皮层的发育过程中，神经元和灰细胞从心室区衍生出来，并迁移到大脑表面的其他部分。许多基因参与这个过程，包括那些导致神经发育和精神疾病的基因。我们正在讨论他们在这个过程中的三种行为的功能。
最近，我们报道了星形胶质细胞祖细胞呈现两种不同的迁移模式:不稳定迁移和血管引导迁移。这些观察是结合本视频中介绍的血清型特异性标记和时间观察方法进行的。为了调平细胞，我们利用宫内电穿孔系统，我们开发的该系统以高信噪比可视化单个细胞。
这种体内基因转移系统还使我们能够通过电穿孔其表达或中子载体，轻松地对给定基因进行功能获得或功能丧失实验。使用这个实验系统，我们旨在观察神经元、神经胶质细胞和血管的细胞行为，并阐明它们之间的串扰。这些研究的结果将有助于了解神经发育障碍的发病机制。
概述
本研究聚焦于大脑皮层的发育，特别强调神经元和胶质前体细胞从脑室区迁移至大脑表面。通过采用时间序列成像技术和体内电穿孔细胞标记，该研究探讨了星形胶质细胞前体细胞的迁移模式以及影响神经发育和精神疾病的基因。
关键研究组成部分
科学领域
- 神经发育
- 细胞迁移
- 神经生物学
背景
- 该研究探索了皮层发育过程中神经元和胶质细胞的起源。
- 研究讨论了特定基因在神经发育和精神疾病中的作用。
- 星形胶质细胞前体细胞展示了与皮层形成相关的不同迁移模式。
- 体内基因转移技术促进了对这些迁移模式的观察。
研究目的
- 可视化并分析迁移中的神经元和胶质细胞的行为。
- 阐明神经发育中相关基因的功能作用。
- 研究神经元、胶质细胞和血管之间的细胞行为和相互作用。
使用的方法
- 利用体内电穿孔进行基因转移和细胞标记。
- 专注于小鼠模型，以检查神经元和胶质前体细胞的迁移。
- 包含EGFP和RFP阳性细胞的时间序列成像。
- 该协议概述了用于准确观察的具体手术和成像技术。
- 包括通过振动显微切片机制作脑切片以进行分析。
主要结果
- 确定了两种不同的星形胶质细胞前体迁移模式：杂乱无章和血管引导。
- 数据呈现了迁移细胞随时间变化的明确轨迹。
- 研究结果有助于理解神经发育障碍的机制。
- 展示了电穿孔在可视化单个细胞方面的有效性。
结论
- 本研究提供了皮层发育过程中神经元迁移机制的洞见。
- 研究结果可能增强我们对神经发育和精神疾病的理解。
- 结果强调了大脑发育中胶质和血管成分之间复杂的相互作用。
常见问题
使用体内电穿孔的优点是什么？
体内电穿孔允许精确的基因转移和特定细胞的体内标记，提供了对于单个细胞成像至关重要的高信噪比。
实验模型如何有助于理解中枢神经系统的发育？
使用小鼠模型能够观察实时神经元迁移和遗传变异的影响，提供了对大脑发育过程的洞见。
从这种时间序列成像方法可以获得哪些类型的数据？
该方法提供了迁移细胞轨迹的定量数据，使得能够分析不同迁移模式及其随时间变化的动态。
这种方法可以适应其他类型的细胞或条件吗？
是的，该协议可以修改以研究各种类型的细胞或条件，使其成为研究体内不同细胞行为方面的多功能工具。
本研究使用的方法有哪些局限性？
潜在的局限性包括体内操作的复杂性和基因递送的特异性，这可能会影响不同实验之间的可重复性。
本研究重点关注哪些细胞行为？
该研究集中于神经元和胶质细胞的迁移模式，特别调查了星形胶质细胞前体细胞在皮层发育过程中如何导航。
Executive Industry Relevance
Time-lapse imaging of migrating neurons and glial progenitors in embryonic mouse brain slices enables direct visualization of cellular dynamics underlying neurodevelopmental processes. This capability is critical for de-risking target validation and understanding gene function in disease-relevant systems, particularly for neurodevelopmental and psychiatric disorder portfolios. The approach supports predictive confidence in early discovery by linking genetic perturbations to quantifiable cellular behaviors.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional interrogation of candidate genes implicated in neurodevelopmental disorders.
- Supports mechanistic de-risking by revealing how genetic modifications alter neuronal and glial migration.
- Facilitates high-confidence target validation through direct observation of cellular phenotypes.
- Provides a platform for gain-of-function and loss-of-function studies in a physiologically relevant context.
Screening & Assay Development
- Establishes validated brain slice systems for quantitative analysis of cell migration dynamics.
- Delivers reproducible, high signal-to-noise imaging outputs suitable for downstream screening workflows.
- Enables standardization of migration assays for comparative evaluation of genetic or pharmacological interventions.
- Supports scalability for multiplexed analysis of multiple gene perturbations.
Translational & Preclinical Research
- Aligns with disease-relevant models by recapitulating in vivo neurodevelopmental processes.
- Provides translational continuity from genetic discovery to preclinical validation of mechanistic hypotheses.
- Enables risk-adjusted advancement decisions based on quantitative migration phenotypes linked to disease genes.
- Supports biomarker identification through dynamic cellular readouts.
Pipeline & Workflow Integration
This method integrates into the discovery continuum from early gene function studies through preclinical model validation, bridging target identification and mechanistic de-risking.
- Discovery Biology: Supports hypothesis testing on gene function in neuronal and glial migration.
- Screening: Provides quantitative, reproducible migration metrics for assay development.
- Analytics: Enables measurement of migration speed, trajectory, and mode for comparative analysis.
- Translational Research: Connects genetic perturbations to disease-relevant cellular behaviors in preclinical models.
- Enterprise Reuse: Offers a reusable imaging and analysis platform for diverse neurodevelopmental gene targets.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and mechanistic understanding.
- Operational Value: Delivers standardized, scalable imaging workflows for cross-project use.
- Strategic Value: Improves go/no-go decisions by linking gene perturbations to functional cellular outcomes.
- Portfolio Impact: Enables risk-adjusted prioritization of neurodevelopmental disorder targets.
Implementation Considerations
- Requires expertise in embryonic brain dissection, in utero electroporation, and advanced imaging.
- Demands access to high-resolution fluorescence microscopy and time-lapse imaging infrastructure.
- Necessitates standardized protocols for reproducibility across teams and projects.
- Adaptation may be needed for different genetic constructs or model systems.
- Potential limitations include technical complexity and throughput constraints inherent to live tissue imaging.
Biopharma FAQs
Why does null hypothesis testing matter for gene perturbation studies?
Null hypothesis testing is essential for determining whether observed changes in neuronal or glial migration after gene perturbation are statistically significant, supporting robust target validation decisions in neurodevelopmental research.
How does independent variable isolation fit the migration assay workflow?
Isolating the independent variable, such as a specific gene knockdown or overexpression, ensures that changes in migration dynamics are attributable to the targeted intervention, increasing confidence in mechanistic conclusions.
What do quantitative migration measurements enable in discovery?
Quantitative measurements of migration speed and trajectory provide objective endpoints for comparing genetic or pharmacological interventions, enabling data-driven prioritization of targets and hypotheses.
Why are replication requirements critical for cross-functional teams?
Replication of migration assays across experiments and teams ensures reproducibility and reliability of findings, facilitating cross-functional collaboration and portfolio-wide data integration.
Which statistical analysis capabilities are required before implementation?
Robust statistical analysis tools are needed to evaluate migration data, assess significance, and control for variability, ensuring that results inform actionable R&D decisions.
